Molecular hybridization combining tumor homing and penetrating peptide domains for cellular targeting

Drug Deliv Transl Res. 2022 May;12(5):1285-1292. doi: 10.1007/s13346-021-01035-z. Epub 2021 Jul 31.

Abstract

A complete peptide-based drug delivery unit has been designed with a tumor homing domain chemically linked to a syndiotactic cell-penetrating domain. The designed peptides were synthesized, characterized, and tested in vitro for cellular uptake and cytotoxicity evaluation. The differential uptake, cellular internalization, negligible hemotoxicity, selective toxicity to MDA-MB-231 breast cancer cells, and the superior penetration in three-dimensional MDA-MB-231 tumorospheres confirm their utility as a promising delivery vector.

Keywords: Cell-penetrating peptide; Drug delivery; Drug design; Tumor homing peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Cell Line, Tumor
  • Cell-Penetrating Peptides* / chemistry
  • Drug Delivery Systems
  • Protein Domains

Substances

  • Antineoplastic Agents
  • Cell-Penetrating Peptides